| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 132, 123-144, Copyright © 1988 by American Society for Investigative Pathology
REGULAR ARTICLES |
R Moll, T Achtstatter, E Becht, J Balcarova-Stander, M Ittensohn and WW Franke
Department of Pathology, University of Mainz Medical School, Federal Republic of Germany.
The pattern of cytokeratins expressed in normal urothelium has been compared with that of various forms of transitional cell carcinomas (TCCs; 21 cases) and cultured bladder carcinoma cell lines, using immunolocalization and gel electrophoretic techniques. In normal urothelium, all simple-epithelium-type cytokeratins (polypeptides 7, 8, 18, 19) were detected in all cell layers, whereas antibodies to cytokeratins typical for stratified epithelia reacted with certain basal cells only or, in the case of cytokeratin 13, with cells of the basal and intermediate layers. This pattern was essentially maintained in low-grade (G1, G1/2) TCCs but was remarkably modified in G2 TCCs. In G3 TCCs simple-epithelial cytokeratins were predominant whereas the amounts of component 13 were greatly reduced. Squamous metaplasia was accompanied generally by increased or new expression of some stratified- epithelial cytokeratins. The cytokeratin patterns of cell culture lines RT-112 and RT-4 resembled those of G1 and G2 TCCs, whereas cell line T- 24 was comparable to G3 carcinomas. The cell line EJ showed a markedly different pattern. The results indicate that, in the cell layers of the urothelium, the synthesis of stratification-related cytokeratins such as component 13 is inversely oriented compared with that in other stratified epithelia where these proteins are suprabasally expressed, that TCCs retain certain intrinsic cytoskeletal features of urothelium, and that different TCCs can be distinguished by their cytokeratin patterns. The potential value of these observations in histopathologic and cytologic diagnoses is discussed.
This article has been cited by other articles:
![]() |
J. Madoz-Gurpide, M. Canamero, L. Sanchez, J. Solano, P. Alfonso, and J. I. Casal A Proteomics Analysis of Cell Signaling Alterations in Colorectal Cancer Mol. Cell. Proteomics, December 1, 2007; 6(12): 2150 - 2164. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Klein, C. S. Van Pelt, A. L. Sabichi, J. dela Cerda, S. M. Fischer, G. Furstenberger, and K. Muller-Decker Transitional Cell Hyperplasia and Carcinomas in Urinary Bladders of Transgenic Mice with Keratin 5 Promoter-Driven Cyclooxygenase-2 Overexpression Cancer Res., March 1, 2005; 65(5): 1808 - 1813. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ramos-Vara, M. A. Miller, M. Boucher, A. Roudabush, and G. C. Johnson Immunohistochemical Detection of Uroplakin III, Cytokeratin 7, and Cytokeratin 20 in Canine Urothelial Tumors Vet. Pathol., January 1, 2003; 40(1): 55 - 62. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Celis, P. Celis, H. Palsdottir, M. Ostergaard, P. Gromov, H. Primdahl, T. F. Orntoft, H. Wolf, A. Celis, and I. Gromova Proteomic Strategies to Reveal Tumor Heterogeneity among Urothelial Papillomas Mol. Cell. Proteomics, April 1, 2002; 1(4): 269 - 279. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Morifuji, S.’i. Taniguchi, H. Sakai, Y. Nakabeppu, and M. Ohishi Differential Expression of Cytokeratin after Orthotopic Implantation of Newly Established Human Tongue Cancer Cell Lines of Defined Metastatic Ability Am. J. Pathol., April 1, 2000; 156(4): 1317 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Lobban, B. A. Smith, G. D. Hall, P. Harnden, P. Roberts, P. J. Selby, L. K. Trejdosiewicz, and J. Southgate Uroplakin Gene Expression by Normal and Neoplastic Human Urothelium Am. J. Pathol., December 1, 1998; 153(6): 1957 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ehler, P. S. Jat, M. D. Noble, S. Citi, and A. Draeger Vascular Smooth Muscle Cells of H-2Kb-tsA58 Transgenic Mice : Characterization of Cell Lines With Distinct Properties Circulation, December 1, 1995; 92(11): 3289 - 3296. [Abstract] [Full Text] |
||||
![]() |
H. Eto, S. S. Yoon, B. P. Bode, S. Kamidono, K. Makino, H. Saya, H. Nakamura, and K. K. Tanabe Mapping and Regulation of the Tumor-associated Epitope Recognized by Monoclonal Antibody RS-11 J. Biol. Chem., August 25, 2000; 275(35): 27075 - 27083. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |